Condition
Metabolic Flexibility
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07799662Not ApplicableCompleted
VO2max and Substrate Crossover Point
NCT07405385Not ApplicableNot Yet Recruiting
REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial.
NCT07096011Recruiting
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
NCT05282355Not ApplicableCompletedPrimary
Astaxanthin Reduces Exercising Heart Rate.
NCT04773132Not ApplicableCompletedPrimary
Human Metabolic Flexibility: Its Role in Energy Regulation and Obesity
NCT02519127Not ApplicableCompletedPrimary
Metflex: The Effectiveness of a Dietary Intervention
Showing all 6 trials